retatrutide clinical trial weight loss results Peptide Series #3 — 🧬🏃🏻‍♀️ BOOM🔥! The most POWERFUL DRUG EVER tested in a isn't approved yet. But the data is already rewriting what we thought was This weight-loss drug hasn't been

Longer term For longer protocols, review metabolic, kidney, liver, and cardiovascular trends every 3-6 months with a clinician

Individuals with gallbladder disease or history of gallstones should be monitored, as rapid weight loss can precipitate gallstone formation

Cardiovascular Protection: Major clinical trials like the LEADER trial for liraglutide have shown that GLP-1 RAs can significantly reduce the risk of major adverse cardiovascular events, such as heart attacks and strokes, in patients with type 2 diabetes

In this review I cover pros and cons, how these drops compare to injectable GLP-1s, and what to expect from a telehealth program that prescribes them